Humana Continues Legal Efforts to Boost Medicare Advantage Ratings

MT Newswires Live
2025/04/17

Humana (HUM) is seeking to overturn an administrative appeal denial by the Centers for Medicare and Medicaid Services this week, upholding an October ratings downgrade that could potentially cost the health insurer billions of dollars in revenue.

A CMS administrative panel on Tuesday turned down Humana's bid to reverse the agency's ratings cuts of several Humana Medicare Advantage plans, the company disclosed in a court filing. It filed lawsuit in

a federal court in Texas soon after CMS trimmed its star ratings for the Medicare Advantage plans citing dropped calls and other problems for customers trying to reach Humana's call centers.

Reduced quality ratings have the effect of shifting many of Medicare customer to less lucrative plans. CMS also provides quality bonuses to plans with higher ratings, with the amounts reaching "hundreds of millions or even billions of dollars annually," the company said in its original complaint.

Humana has one more chance to convince the agency for reversal by April 28 before it can become official, according to the filing. If denied again, Humana expects to continue its legal fight before US District Court Judge Reed O'Connor in Texas.

Price: 283.33, Change: -3.45, Percent Change: -1.20

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10